Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, Monoclonal and Polyclonal Antibodies Research, and Viral gastroenteritis research and epidemiology.
Computationally restoring the potency of a clinical antibody against Omicron
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
An Egg-Derived Sulfated <i>N</i> -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines
Potently neutralizing and protective human antibodies against SARS-CoV-2
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein–Based Influenza Vaccines During the 2017–2018 Season
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season